Malignant News and Research

RSS

Mayo Clinic study: Patients with Parkinson's have higher risk of melanoma and vice versa

People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds.

5 Jul 2017

Timing of mutations can have effect on health and disease

A single genetic mutation can lead to completely different diseases, depending on the time and location at which the mutation occurs.

30 Jun 2017

DNA methylation can provide effective markers for major cancers, study reveals

In a new study, published online in the July 26 issue of PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective markers for at least four major cancers, not only correctly differentiating malignant tissues from normal, but also providing information on prognosis and survival.

28 Jun 2017

Research team receives NIH grant to develop new way to examine cancer cell metastasis

A University of Delaware researcher is part of a team that recently received a grant from the National Institutes of Health to develop a new way to examine how cancer cells metastasize.

28 Jun 2017

Two-test combination accurately identifies benign pancreatic lesions

When performed in tandem, two molecular biology laboratory tests distinguish, with near certainty, pancreatic lesions that mimic early signs of cancer but are completely benign.

23 Jun 2017

New laser imaging 'bowl' could reduce stages involved in spotting breast cancer

In a bid to make the world's first while-you-wait test for breast cancer, European scientists are developing a comfortable hemispherical bowl lined with laser sources and ultrasound detectors with the potential to reduce the stages in spotting the disease into a single appointment.

20 Jun 2017

Cells key to blood vessel formation can also produce tumors and enable their spread

While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.

20 Jun 2017

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually curable with traditional therapies like surgery, radiation, and chemotherapy.

20 Jun 2017

New treatment strategy may destroy difficult-to-treat brain tumors

A new strategy for treating brain tumors may extend or save the lives of patients diagnosed with one of the deadliest forms of cancer, according to a study from UT Southwestern Medical Center.

13 Jun 2017

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.

13 Jun 2017

Berlin meeting of colorectal specialists to drive best practice and innovation

It is less than five months to go until the 2017 ESCP Meeting, which is taking place in Berlin between 20 and 21 September. The meeting, hosted by the European Society of Coloproctology, brings together global experts to drive innovation and best practice in the field and will feature the latest coloproctological research.

8 Jun 2017

Study establishes BCL6 protein as potential marker to predict overall survival of GBM patients

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.

7 Jun 2017

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

St. Jude Children's Research Hospital molecular biologists have identified an enzyme that activates and "supercharges" cellular machinery that controls how cells become specialized cells in the body.

7 Jun 2017

Scientists locate crucial off-switch for central cell control

As the cell's molecular control center, the mTor kinase regulates cellular metabolism, growth and division. However, in cells affected by pathological change, the regulation goes array.

2 Jun 2017

Investigational compound inhibits cancer-specific mutations in mice

Many malignancies develop as a result of genetic alterations in individual cells. These gene mutations often cause altered proteins that give new, growth-promoting properties to the cell.

30 May 2017

Researchers can attack cancer by working together, says UNC Charlotte professor

MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.

27 May 2017

Researchers use chemical array to find malignant cells within melanoma tumor

Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within a melanoma tumor that hold the potential to spread.

26 May 2017

Safety tips to help decrease risk for developing skin cancer

Did you know that skin cancer is highly preventable? Because May is National Skin Cancer Awareness Month, we want to highlight the fact that our lifestyle choices contribute greatly to our chances of getting skin cancer.

26 May 2017

Melanoma could affect anyone regardless of skin color

Sidney Brown thought the mole on his nose was just an annoying pimple. He didn't consider that it could be a cancerous tumor, because, Brown thought, "skin cancer is something white people get."

23 May 2017

FAU researchers use robot technology to gain insights into development of malignant melanoma

Malignant melanoma is one of the most common and dangerous types of cancer. Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg investigated how and why brown pigmented moles turn into malignant melanoma using innovative robot technology.

23 May 2017

Malignant News and Research

Mayo Clinic study: Patients with Parkinson's have higher risk of melanoma and vice versa

Timing of mutations can have effect on health and disease

DNA methylation can provide effective markers for major cancers, study reveals

Research team receives NIH grant to develop new way to examine cancer cell metastasis

Two-test combination accurately identifies benign pancreatic lesions

New laser imaging 'bowl' could reduce stages involved in spotting breast cancer

Cells key to blood vessel formation can also produce tumors and enable their spread

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

New treatment strategy may destroy difficult-to-treat brain tumors

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Berlin meeting of colorectal specialists to drive best practice and innovation

Study establishes BCL6 protein as potential marker to predict overall survival of GBM patients

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

Scientists locate crucial off-switch for central cell control

Investigational compound inhibits cancer-specific mutations in mice

Researchers can attack cancer by working together, says UNC Charlotte professor

Researchers use chemical array to find malignant cells within melanoma tumor

Safety tips to help decrease risk for developing skin cancer

Melanoma could affect anyone regardless of skin color

FAU researchers use robot technology to gain insights into development of malignant melanoma

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News